ARTICLES ON HEART FAILURE AND CIRCULATORY DEVICES
Surgical treatment of tricuspid regurgitation: a new ally in patients with long-term ventricular assist devices?
A randomized US trial aimed to determine whether concomitant tricuspid valve surgery (TVS) at the time of durable left ventricular assist device (LVAD) implantation reduces tricuspid regurgitation (TR) and the incidence of long-term right heart failure (RHF).
Ventricular support in children with congenital heart disease: time to join “ACTION” promptly!
This study analyzes data from the ACTION registry to assess whether morbidity and mortality after ventricular assist device (VAD) implantation differ between children with and without congenital heart disease (CHD), and whether outcomes among those with CHD vary according to anatomy (single- vs. biventricular).
Outcomes after hospital discharge in children requiring post-cardiotomy extracorporeal membrane oxygenation: is survival enough?
This retrospective observational study describes the experience of the binational ANZCORS registry involving 376 pediatric patients who required extracorporeal membrane oxygenation (ECMO) following cardiac surgery.
Omentoplasty: an old ally to the rescue in ventricular assist device infections
Single-center retrospective study assessing the utility of omentoplasty in patients with left ventricular assist device (LVAD) infections.
A new paradigm in pediatric circulatory support
This single-center retrospective observational study presents a case series of pediatric patients with cardiogenic shock managed using the Impella device.
What can the US learn from the Spanish heart transplantation model?
Results from the US heart transplant program between 2016 and 2022, analyzing demographic characteristics, mortality, and 30-day readmissions in heart transplant recipients.
The reinvention of ECMO: strategies that break the VA/VV mold
Editorial commentary on novel cannulation strategies in extracorporeal membrane oxygenation (ECMO) recently published in the Journal of Cardiothoracic and Vascular Anesthesia, proposing technical alternatives to standard VA or VV-ECMO support. These alternative approaches may be particularly valuable in cases of complex pathophysiology, high cardiac output, right ventricular failure, or when conventional devices are contraindicated.
Surgical explantation of the HeartMate 3: step-by-step technique and insights from recent clinical experience
Visual and annotated summary of a surgical tutorial video on the explantation of the HeartMate 3 during orthotopic heart transplantation, complemented by recent evidence on surgical approaches, explant techniques, and clinical outcomes.
Impella CP in post-infarction cardiogenic shock: does age matter?
This substudy of the DanGer Shock trial assessed outcomes associated with the use of Impella CP® for the management of cardiogenic shock (CS) secondary to myocardial infarction (MI) according to patient age.
Donor selection in heart transplantation in 2025: expanding the transplant horizon
This state-of-the-art document provides an overview of current donor selection strategies in heart transplantation (HT), highlighting how technical advances have enabled an expansion in the donor pool and increased transplant rates.